Evaluating the Efficacy of Bacteriophage Therapy against Multidrug-Resistant Klebsiella pneumoniae Infections

Multidrug-resistant (MDR) Klebsiella pneumoniae poses a significant challenge to conventional antibiotic treatments. This study aims to assess the efficacy of bacteriophage therapy against MDR Klebsiella pneumoniae through a combination of in vitro assays, animal model experiments, and clinical case reviews. Phages isolated from environmental samples demonstrated potent lytic activity against MDR strains. In vitro assays showed that phages significantly reduced bacterial counts at a multiplicity of infection (MOI) of 1 or higher. Animal model experiments revealed that phage therapy, particularly using a cocktail of multiple phages, markedly improved survival rates and reduced bacterial loads in infected tissues compared to saline controls and standard antibiotics. Clinical case reviews indicated that patients receiving phage therapy experienced high rates of bacterial clearance and clinical improvement. These findings support the potential of bacteriophage therapy as an effective alternative or adjunct to traditional antibiotics in managing MDR Klebsiella pneumoniae infections.